From the Guidelines
The appropriate regimen for Afrin (oxymetazoline) is to use it for no more than 3 to 5 consecutive days due to the risk of rebound congestion and rhinitis medicamentosa.
Key Considerations
- The package insert for oxymetazoline nasal spray recommends use for no more than 3 days 1
- Rebound congestion may occur as soon as the third or fourth day of treatment 1
- Topical decongestants should not be used more than 3 to 5 consecutive days without a prolonged intervening drug-free period 1
- Adding topical oxymetazoline to intranasal corticosteroids for a few days has proven benefit in severe nasal obstruction, but use should be limited due to concerns about nasal rebound 1
Important Details
- Rhinitis medicamentosa may develop at 3 days of use, and longer treatment regimens should be entertained only with caution 1
- First-line treatment of rhinitis medicamentosa consists of suspending topical decongestant use to allow the nasal mucosa to recover, and intranasal corticosteroids and oral steroids may be used to hasten recovery 1
- The development of rhinitis medicamentosa is highly variable, and may develop within 3 days of use or fail to develop after 6 weeks of daily use 1
From the FDA Drug Label
When using this product: do not use more than directed Do not use for more than 3 days. Use only as directed. The appropriate regimen for Afrin (oxymetazoline) is to:
- Use no more than directed
- Not use for more than 3 days 2
From the Research
Appropriate Regimen for Afrin (Oxymetazoline)
- The use of oxymetazoline nasal spray is generally limited to a maximum of 10 days due to the risk of developing rebound mucosal swelling and rhinitis medicamentosa 3.
- A study found that it is safe to use topical nasal oxymetazoline with or without benzalkonium chloride for 10 days in patients with vasomotor rhinitis, with no rebound swelling observed after treatment 3.
- Oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours, with statistically significant changes from baseline in subjective nasal congestion and objective measures of nasal patency 4.
- The use of nasal steroids with oxymetazoline was found to be more effective over 6 weeks than nasal steroids alone in improving blocked nose, hyposmia, nasal mucociliary clearance, and polyp size in the treatment of nasal polyposis 5.
- In pediatric patients, caution should be exercised when using oxymetazoline due to the risk of severe poisoning, especially when inverting the container, which can increase the volume delivered 20- to 30-fold compared with holding it upright 6, 7.